Immunohistochemical patterns for α- and β-catenin, E- and N-cadherin expression in ovarian epithelial tumors

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gynecologic Oncology

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YGYNO.2004.03.037
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biostatistics: a Methodology for the Health Sciences

  2005cited by this paper
• The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis.

  2002cited by this paper
• The Molecular Perspective: Cadherin

  2002cited by this paper
• Prognostication of invasive ductal breast cancer by quantification of E‐cadherin immunostaining: themethodology and clinical relevance

  2002cited by this paper
• Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough.

  2001cited by this paper
• Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.

  2001cited by this paper
• Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus.

  2000cited by this paper
• Re‐expression of E‐cadherin, α‐catenin and β‐catenin, but not of γ‐catenin, in metastatic tissue from breast cancer patients

  2000cited by this paper
• E‐cadherin and α‐, β‐, and γ‐catenin protein expression is up‐regulated in ovarian carcinoma cells in serous effusions

  2000cited by this paper
• β‐Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours

  1999cited by this paper
• Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: Influence of family history of ovarian cancer

  1999cited by this paper
• E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.

  1999cited by this paper
• Expression of E‐cadherin, α‐catenin and β‐catenin in normal ovarian surface epithelium and epithelial ovarian cancers

  1998cited by this paper
• Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer.

  1998cited by this paper
• Expression of wild-type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both growth regulation and tumor suppressor activities

  1997cited by this paper
• E‐cadherin expression in human epithelial ovarian cancer and normal ovary

  1997cited by this paper
• A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group.

  1997cited by this paper
• Differential expression of the cell‐cell adhesion molecule E‐cadherin in ascites and solid human ovarian tumor cells

  1994cited by this paper
• Mutations of the E–cadherin gene in human gynecologic cancers

  1994cited by this paper
• Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: Biological significance and clinical implications

  1993cited by this paper
• Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization.

  1992cited by this paper

• Differential analysis of histopathological and genetic markers of cancer aggressiveness, and survival difference in EBV-positive and EBV-negative prostate carcinoma

  2024cites this paper
• CD103+ Cells and Chemokine Receptor Expression in Breast Cancer

  2023cites this paper
• High N-Cadherin Protein Expression in Ovarian Cancer Predicts Poor Survival and Triggers Cell Invasion

  2022cites this paper
• The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.

  2020cites this paper
• Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy

  2020cites this paper
• Biologic Mechanisms Linked to Prognosis in Ovarian Cancer that May Be Affected by Aging

  2019cites this paper
• Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface

  2018cites this paper
• Upregulated N‐cadherin expression is associated with poor prognosis in epithelial‐derived solid tumours: A meta‐analysis

  2018cites this paper
• SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells

  2017cites this paper
• TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.

  2016cites this paper
• Cooperation of Tyrosine Kinase Receptor TrkB and Epidermal Growth Factor Receptor Signaling Enhances Migration and Dispersal of Lung Tumor Cells

  2014cites this paper
• Immunohistochemical Analysis of WT1, EGFR, E-cadherin, beta-catenin and p53 in 43 Moroccan Epithelial Ovarian Tumours

  2014cites this paper
• Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy

  2014cites this paper
• Tumor-Infiltrating Lymphocytes Expressing the Tissue Resident Memory Marker CD103 Are Associated with Increased Survival in High-Grade Serous Ovarian Cancer

  2013cites this paper
• Modeling Tumorigenesis in Drosophila: Current Advances and Future Perspectives

  2013cites this paper
• E-cadherin nuclear staining is useful for the diagnosis of ovarian adult granulosa cell tumor.

  2012cites this paper
• E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis

  2011cites this paper
• Low membranous expression of β-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary

  2010cites this paper
• Targeting locoregional peritoneal dissemination in ovarian cancer

  2009cites this paper
• E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells

  2009cites this paper
• Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression

  2008cites this paper
• Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.

  2008cites this paper
• Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

  2008cites this paper
• The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression.

  2008cites this paper
• Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.

  2007cites this paper
• The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients

  2007cites this paper
• Prognostic Significance of Cell-Matrix Interactions in Epithelial Ovarian Cancer

  2007cites this paper
• Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.

  2006cites this paper
• Prognostic significance of E-cadherin–catenin complex in epithelial ovarian cancer

  2006cites this paper
• The N-cadherin ectodomain: fate and finction outside the cancer cell

  2006cites this paper
• Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours

  2006cites this paper
• Molecular biomarkers: new approaches in ovarian cancer diagnosis

  2006cites this paper
• Ovarian Cancer Metastasis: Integrating insights from disparate model organisms

  2005cites this paper
• Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases.

  2005cites this paper
• Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

  2005cites this paper
• beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.

  2005cites this paper
• Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer.

  2005cites this paper